Targeting Mitochondria 2020 will be a Virtual and In-Person Congress


We have been closely following updates and evolving guidance from local, national and global agencies for COVID-19. There is still much uncertainty around the coronavirus, and how long our communities may be impacted by the pandemic, but it seems certain that decisions about how we work, travel and gather together will continue to be influenced for weeks and months still to come. Today, we have made the decision to combine the In-Person and Virtual conference.


If you cannot attend in-person or virtual due to the restriction and time zone difference, you can access on-demand videos to this entire event, including synced audio/video and slides.

All posters will be in PDF format. You can visit them, upload and interact directly with the poster presenter. You can also exchange with speakers via direct or private exchange during the conference.


We will keep you informed of any new decision.

Mitochondria-targeted low-molecular weight compounds for probing mitochondrial function

Richard-C.-Hartley-Mitochondria-2019-congressThe Scientific Committee of WMS is honored to announce that Prof. Richard C. Hartley, Professor of Chemical Biology from University of Glasgow, United Kingdom, will be joining us for our 10th Anniversary Edition of Targeting Mitochondria World Congress, which will be held in Berlin on October 28th-29th, 2019.

During the Congress Prof. Richard C. Hartley will speak about "Mitochondria-targeted low-molecular weight compounds for probing mitochondrial functions".

The Hartley group specializes in designer small molecules targeted to accumulate in the mitochondrial matrix.  These can be used both to detect and manipulate mitochondrial redox processes.  Examples include compounds for mitochondrial  superoxide detection (MitoNeoD) and generation (MitoPQ), for selective depletion of mitochondrial antioxidant defences (MitoCDNB), and for mitochondrial protection (MitoGamide).  Synthetic chemicals can also be used to mimic mitochondrial signaling and modulate inflammatory responses (octyl itaconate).


For more information about Targeting Mitochondria 2019: